Cargando…

Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome

OBJECTIVE: Our study aimed to investigate the relationship between polymorphisms (Apa1, Bsm1, Fok1, and Cdx2) in the VDR gene as well as AMH and AMHR2 genes and their influence on AMH and 25(OH)D levels in PCOS women. STUDY DESIGN: Seventy-five patients with PCOS and 23 control women were included....

Descripción completa

Detalles Bibliográficos
Autores principales:	Szafarowska, Monika, Dziech, Edyta, Kaleta, Beata, Kniotek, Monika, Rogowski, Artur, Segiet - Święcicka, Agnieszka, Jerzak, Małgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Reproductive Physiology and Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602978/ https://www.ncbi.nlm.nih.gov/pubmed/31089932 http://dx.doi.org/10.1007/s10815-019-01472-3

Ejemplares similares

Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic
por: Jerzak, Małgorzata, et al.
Publicado: (2022)

Differences in the Expression of KIR, ILT Inhibitory Receptors, and VEGF Production in the Induced Decidual NK Cell Cultures of Fertile and RPL Women
por: Kniotek, Monika, et al.
Publicado: (2021)

OR35-04 Anti-Müllerian Hormone Variants identified in Patients with Polycystic Ovary Syndrome Affect Secretion and Immunoactivity
por: Meng, Li, et al.
Publicado: (2023)

Decreased Production of TNF-α and IL-6 Inflammatory Cytokines in Non-Pregnant Idiopathic RPL Women Immunomodulatory Effect of Sildenafil Citrate on the Cellular Response of Idiopathic RPL Women
por: Kniotek, Monika, et al.
Publicado: (2021)

Sildenafil Citrate Downregulates PDE5A mRNA Expression in Women with Recurrent Pregnancy Loss without Altering Angiogenic Factors—A Preliminary Study
por: Kniotek, Monika, et al.
Publicado: (2021)

SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
por: Raymond Li, Hang Wun, et al.
Publicado: (2020)

Elevated ovarian pentraxin 3 in polycystic ovary syndrome
por: Pan, Jiexue, et al.
Publicado: (2021)

Symptoms and Quality of Life Changes after Hysteroscopic Treatment in Patients with Symptomatic Isthmocele—Preliminary Results
por: Szafarowska, Monika, et al.
Publicado: (2021)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Elevated Anti-Müllerian Hormone Levels in Newborns of Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis Based on Observational Studies
por: Zhou, Siyu, et al.
Publicado: (2021)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

ODP642 Differences in hormonal profiles and vitamin D status depending on the insulin sensitivity status in women with polycystic ovary syndrome (PCOS).
por: Ozga-Piszczek, Katarzyna, et al.
Publicado: (2022)

PMON243 Metabolic Disorders Genetically Modify Polycystic Ovary Syndrome through its Candidate Hormones
por: Actkins, Ky’Era, et al.
Publicado: (2022)

FRI426 Raised Thyroid Stimulating Hormone In Girls With Polycystic Ovary SyndromeEffects Of Randomized Interventions
por: Ibanez, Lourdes, et al.
Publicado: (2023)

MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome
por: Legro, Richard, et al.
Publicado: (2019)

Effect of anti-müllerian hormone on the development and selection of ovarian follicle in hens
por: Huang, S.J., et al.
Publicado: (2020)

SAT-017 Relationship Between Vitamin D Levels and Signs of Polycystic Ovary Syndrome
por: Smykalova, Anastasia, et al.
Publicado: (2020)

MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
por: Maidana, Patricia Nieves Amelia, et al.
Publicado: (2020)

Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome
por: Dursun, Fatma, et al.
Publicado: (2016)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran, Yu, et al.
Publicado: (2021)

Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
por: di Clemente, Nathalie, et al.
Publicado: (2022)

The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
por: Sivanandy, Mala S., et al.
Publicado: (2023)

SAT-194 Correlation of Capillary and Venous Plasma Measurements of Anti-Müllerian Hormone
por: Adams, Hadar, et al.
Publicado: (2019)

Anti-Mullerian Hormone Protein-Altering Variants Are Associated With Hypertriglyceridemia in the General Population
por: Chang, Sydney, et al.
Publicado: (2021)

THU627 Fertility Outcomes And Anti Mullerian Hormone Levels In Women With Hypopituitarism
por: Fitz, Victoria W, et al.
Publicado: (2023)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
por: Serin, Aliye Nigar, et al.
Publicado: (2021)

OR35-03 Uncovering Causative Mutations in Polycystic Ovary Syndrome
por: Srivastava, Jaya, et al.
Publicado: (2023)

FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
por: Husby, Anne Engtrø, et al.
Publicado: (2023)

Letter to the Editor: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Joob, Beuy, et al.
Publicado: (2013)

The Author Response: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Kim, Hye Ok
Publicado: (2013)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate
por: Hestiantoro, Andon, et al.
Publicado: (2016)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
por: Yue, Chao-Yan, et al.
Publicado: (2018)

Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
por: Ahmed, Nada, et al.
Publicado: (2019)

Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
por: Mimouni, Nour El Houda, et al.
Publicado: (2021)

Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value
por: Song, Do Kyeong, et al.
Publicado: (2017)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b3aolbm55cu3ojk950qk9gnu1e